Briem S[au] - Search Results

Year	Number of Results
1990	1
2004	1
2005	1
2007	3
2008	1
2009	2
2011	3
2012	1
2013	1
2014	1
2016	1
2019	1
2023	0

1

Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department.

Sohlenius-Sternbeck AK, Janson J, Bylund J, Baranczewski P, Breitholtz-Emanuelsson A, Hu Y, Tsoi C, Lindgren A, Gissberg O, Bueters T, Briem S, Juric S, Johansson J, Bergh M, Hoogstraate J. Sohlenius-Sternbeck AK, et al. Among authors: briem s. Curr Drug Metab. 2016;17(3):253-70. doi: 10.2174/1389200217666151210125637. Curr Drug Metab. 2016. PMID: 26651977 Review.

2

[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

Benesova K, Lorenz HM, Lion V, Voigt A, Krause A, Sander O, Schneider M, Feuchtenberger M, Nigg A, Leipe J, Briem S, Tiessen E, Haas F, Rihl M, Meyer-Olson D, Baraliakos X, Braun J, Schwarting A, Dreher M, Witte T, Assmann G, Hoeper K, Schmidt RE, Bartz-Bazzanella P, Gaubitz M, Specker C. Benesova K, et al. Among authors: briem s. Z Rheumatol. 2019 Oct;78(8):722-742. doi: 10.1007/s00393-019-0683-y. Z Rheumatol. 2019. PMID: 31468170 Review. German.

3

Ward rounds: how prepared are future doctors?

Nikendei C, Kraus B, Schrauth M, Briem S, Jünger J. Nikendei C, et al. Among authors: briem s. Med Teach. 2008 Feb;30(1):88-91. doi: 10.1080/01421590701753468. Med Teach. 2008. PMID: 18278658

4

Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.

Blank N, Max R, Schiller M, Briem S, Lorenz HM. Blank N, et al. Among authors: briem s. Rheumatology (Oxford). 2009 Apr;48(4):440-1. doi: 10.1093/rheumatology/ken491. Epub 2009 Jan 19. Rheumatology (Oxford). 2009. PMID: 19153143 No abstract available.

5

[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].

Briem S, Lorenz HM. Briem S, et al. Z Rheumatol. 2011 Feb;70(2):123-8. doi: 10.1007/s00393-010-0685-2. Z Rheumatol. 2011. PMID: 21267732 German.

6

High-throughput analysis of standardized pharmacokinetic studies in the rat using sample pooling and UPLC-MS/MS.

Bueters T, Dahlström J, Kvalvågnaes K, Betnér I, Briem S. Bueters T, et al. Among authors: briem s. J Pharm Biomed Anal. 2011 Jul 15;55(5):1120-6. doi: 10.1016/j.jpba.2011.03.042. Epub 2011 Apr 6. J Pharm Biomed Anal. 2011. PMID: 21530131

7

Diffusion and absorption of (-)sulpiride and raclopride after intracerebral administration in the rat.

Ahlenius S, Briem S, Hillegaart V, Magnusson O. Ahlenius S, et al. Among authors: briem s. Biochem Pharmacol. 1990 Jun 15;39(12):2066-9. doi: 10.1016/0006-2952(90)90633-v. Biochem Pharmacol. 1990. PMID: 2353948 No abstract available.

8

Combined approach for high-throughput preparation and analysis of plasma samples from exposure studies.

Briem S, Martinsson S, Bueters T, Skoglund E. Briem S, et al. Rapid Commun Mass Spectrom. 2007;21(13):1965-72. doi: 10.1002/rcm.3047. Rapid Commun Mass Spectrom. 2007. PMID: 17526069

9

Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.

Lundquist P, Lööf J, Fagerholm U, Sjögren I, Johansson J, Briem S, Hoogstraate J, Afzelius L, Andersson TB. Lundquist P, et al. Among authors: briem s. Drug Metab Dispos. 2014 Mar;42(3):459-68. doi: 10.1124/dmd.113.054155. Epub 2014 Jan 6. Drug Metab Dispos. 2014. PMID: 24396143

10

Description and validation of a four-channel staggered LC-MS/MS system for high-throughput in vitro screens.

Briem S, Pettersson B, Skoglund E. Briem S, et al. Anal Chem. 2005 Mar 15;77(6):1905-10. doi: 10.1021/ac049077m. Anal Chem. 2005. PMID: 15762603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results